Barbara Bonamassa

Dr. Barbara Bonamassa holds a 3-year Bachelor’s degree in Biological Sciences and a 2-year Master’s degree in Cellular and Molecular Biology from the Alma Mater Studiorum - University of Bologna, Italy. Further to undergraduate studies, she obtained her PhD in Pharmacology and Toxicology at the same University. She has then joined several national laboratories and the University of Pittsburgh, School of Pharmacy (PA, USA) as a postdoctoral researcher supported by national and international fellowships. Her focus has been on the study of gene expression regulation, the development of viral and non-viral gene delivery/transfer techniques as well as the identification of genes that code for therapeutic proteins and the illustration of their mechanisms of action, conducting basic research in cell culture and animal models. After earning a II level master degree in Drug Regulatory Affairs and an advanced study course degree in Statistical Methods for the Biomedical Research and Practice from the University of Rome “Sapienza” (Italy), she has joined the Italian Medicines Agency (AIFA). There, she holds a position as an executive biologist, serving as quality assessors for biological medicinal products with emphasis on ATMPs and Italian Alternate Member at the Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA). Currently, she is also a quality assessor for biotherapeutic products within the ‎World Health Organization (WHO) Prequalification Team – Medicines Assessment Team (PQT/MED).